Dose banding of chemotherapy in the Edinburgh Cancer Centre

Pharmaceutical Journal

Volumn 270, Issue 7249, 2003, Pages 691-693

  MacLean, Fiona ^a   Macintyre, Jill ^a   McDade, Jim ^a   Moyes, Donna ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUDARABINE; FLUOROURACIL; METHOTREXATE;

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER PATIENT; CLINICAL PRACTICE; COLON CANCER; DOSE RESPONSE; FEEDBACK SYSTEM; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MEDICAL AUDIT; NURSING STAFF; ONCOLOGY; OUTCOMES RESEARCH; PATIENT CARE; PHARMACEUTICAL CARE; SAFETY; UNITED KINGDOM; VERBAL COMMUNICATION;

EID: 0038079854     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Cancer scenarios: an aid to planning cancer services in Scotland in the next decade. Edinburgh: The Scottish Executive; 2001.
2. Cancer in Scotland: action for change. NHS HDL 54. Edinburgh: The Scottish Executive; 2001.
3. Du Bois D, Du Bois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863-71.
4. Plumridge R, Sewell G. Dose banding of cytotoxic drugs: a new concept in cancer chemotherapy. Am J Health-Syst Pharm 2001; 58:1760-4.
5. Baker JP, Jones SE. Rationalisation of chemotherapy services in the University Hospital Birmingham NHS Trust. J Oncol Pharm Pract 1998;4:10-14.
6. Clinical standards, breast cancer. Edinburgh: Clinical Standards Board for Scotland; 2001.